BOSTON SCIENTIFIC CORPORATION Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
BOSTON SCIENTIFIC CORPORATION (BSX) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2026-06-30 was $2.00M, a 100.00% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2026-03-31 was $1.00M, a 0.00% change year-over-year.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2025-12-31 was $3.00M.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2025-09-30 was $1.00M, a 90.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2025 was $6.00M.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2024 was -$15.00M.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2023 was -$11.00M.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-08-03 | $3.00M 10-Q · filed 2026-08-03 | $6.00M derived: sum of 3 quarters · filed 2026-08-03 | $7.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2026-03-31 | $1.00M 10-Q · filed 2026-05-01 | $4.00M derived: sum of 2 quarters · filed 2026-05-01 | $5.00M derived: sum of 3 quarters · filed 2026-05-01 | $6.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.00M derived: sum of 2 quarters · filed 2026-02-17 | $5.00M derived: sum of 3 quarters · filed 2026-08-03 | $6.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-03 | $2.00M derived: sum of 2 quarters · filed 2026-08-03 | $3.00M 10-Q · filed 2025-11-03 | -$12.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-06-30 | $1.00M 10-Q · filed 2026-08-03 | $2.00M 10-Q · filed 2026-08-03 | -$13.00M derived: sum of 3 quarters · filed 2026-08-03 | -$3.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-01 | -$14.00M derived: sum of 2 quarters · filed 2026-05-01 | -$4.00M derived: sum of 3 quarters · filed 2026-05-01 | -$8.00M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | -$15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$5.00M derived: sum of 2 quarters · filed 2026-02-17 | -$9.00M derived: sum of 3 quarters · filed 2026-02-17 | -$15.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $10.00M 10-Q · filed 2025-11-03 | -$10.00M 10-Q · filed 2024-11-01 | $6.00M derived: sum of 2 quarters · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | -$27.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$4.00M 10-Q · filed 2025-08-01 | -$10.00M 10-Q · filed 2025-08-01 | -$37.00M derived: sum of 3 quarters · filed 2026-02-17 | -$21.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | -$6.00M 10-Q · filed 2025-05-01 | -$33.00M derived: sum of 2 quarters · filed 2026-02-17 | -$17.00M derived: sum of 3 quarters · filed 2026-02-17 | -$17.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | -$27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$11.00M derived: sum of 2 quarters · filed 2026-02-17 | -$11.00M derived: sum of 3 quarters · filed 2026-02-17 | -$11.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $16.00M 10-Q · filed 2024-11-01 | $16.00M derived: sum of 2 quarters · filed 2024-11-01 | $16.00M 10-Q · filed 2024-11-01 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |